Rongxin X. Yao

Wenzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial.

Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial.

Journal: Haematologica

Published: November 29, 2024

Long-term hypomethylating agents in patients with myelodysplastic syndromes: a multi-center retrospective study

Long-term hypomethylating agents in patients with myelodysplastic syndromes: a multi-center retrospective study

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 22, 2024

Analysis and summary of clinical characteristics of 289 patients with paroxysmal nocturnal hemoglobinuria in Zhejiang Province

Analysis and summary of clinical characteristics of 289 patients with paroxysmal nocturnal hemoglobinuria in Zhejiang Province

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: August 12, 2024

Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China.

Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China.

Journal: Medicine

Published: October 03, 2019

DUXAP10 regulates proliferation and apoptosis of chronic myeloid leukemia via PTEN pathway.

DUXAP10 regulates proliferation and apoptosis of chronic myeloid leukemia via PTEN pathway.

Journal: European review for medical and pharmacological sciences

Published: August 03, 2018

LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma.

LncRNA PDIA3P interacts with c-Myc to regulate cell proliferation via induction of pentose phosphate pathway in multiple myeloma.

Journal: Biochemical and biophysical research communications

Published: February 19, 2018

Update of ALDH as a Potential Biomarker and Therapeutic Target for AML.

Update of ALDH as a Potential Biomarker and Therapeutic Target for AML.

Journal: BioMed research international

Published: September 29, 2017

Analysis of isodicentric Ph chromosomes in chronic myeloid leukemia blast crisis

Analysis of isodicentric Ph chromosomes in chronic myeloid leukemia blast crisis

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics

Published: February 11, 2017

RhIL-11 treatment normalized Th1/Th2 and T-bet/GATA-3 imbalance in in human immune thrombocytopenic purpura (ITP).

RhIL-11 treatment normalized Th1/Th2 and T-bet/GATA-3 imbalance in in human immune thrombocytopenic purpura (ITP).

Journal: International immunopharmacology

Published: March 13, 2016

Downregulation of T-bet/GATA-3 ratio induced by IL-11 treatment is responsible for Th1/Th2 balance restoration in human immune thrombocytopenic purpura (ITP).

Downregulation of T-bet/GATA-3 ratio induced by IL-11 treatment is responsible for Th1/Th2 balance restoration in human immune thrombocytopenic purpura (ITP).

Journal: Journal of thrombosis and thrombolysis

Published: December 17, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026